SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027796
Filing Date
2021-05-14
Accepted
2021-05-14 06:46:02
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cgem-10q_20210331.htm 10-Q 2575526
2 EX-31.1 cgem-ex311_8.htm EX-31.1 20359
3 EX-31.2 cgem-ex312_6.htm EX-31.2 20233
4 EX-32.1 cgem-ex321_7.htm EX-32.1 14704
  Complete submission text file 0001564590-21-027796.txt   8281461

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cgem-20210331.xml EX-101.INS 1835202
6 XBRL TAXONOMY EXTENSION SCHEMA cgem-20210331.xsd EX-101.SCH 59327
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cgem-20210331_cal.xml EX-101.CAL 35647
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cgem-20210331_def.xml EX-101.DEF 167958
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgem-20210331_lab.xml EX-101.LAB 387001
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgem-20210331_pre.xml EX-101.PRE 298033
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39856 | Film No.: 21921875
SIC: 2836 Biological Products, (No Diagnostic Substances)